General Information of the Compound
Compound ID
CP0148608
Compound Name
[4-[4-[2-(dimethylamino)ethyl]piperazin-1-yl]-2-pyridin-2-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-phenylmethanone
    Show/Hide
Structure
Formula
C27H33N7O
Molecular Weight
471.609
Canonical SMILES
CN(C)CCN1CCN(CC1)c1nc(nc2CCN(Cc12)C(=O)c1ccccc1)-c1ccccn1
    Show/Hide
InChI
InChI=1S/C27H33N7O/c1-31(2)14-15-32-16-18-33(19-17-32)26-22-20-34(27(35)21-8-4-3-5-9-21)13-11-23(22)29-25(30-26)24-10-6-7-12-28-24/h3-10,12H,11,13-20H2,1-2H3
    Show/Hide
InChIKey
JQXYJGKUVRHMFA-UHFFFAOYSA-N
Physicochemical Property
logP
2.4207
Rotatable Bonds
6
Heavy Atom Count
35
Polar Areas
68.7
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
35

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 127042199
ChEMBL ID
CHEMBL3745729
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 100000 nM
   TI
   LI
   LO
   TS